These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


136 related items for PubMed ID: 12379923

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Differential effects of sulfate and sulfobutyl ether of beta-cyclodextrin on erythrocyte membranes in vitro.
    Shiotani K, Uehata K, Irie T, Uekama K, Thompson DO, Stella VJ.
    Pharm Res; 1995 Jan; 12(1):78-84. PubMed ID: 7724491
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Cytoprotective effect of 3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate (DY-9760e) against ischemia/reperfusion-induced injury in rat heart involves inhibition of fodrin breakdown and protein tyrosine nitration.
    Hashimoto M, Takada Y, Takeuchi Y, Kasahara J, Hisa H, Shirasaki Y, Fukunaga K.
    J Pharmacol Sci; 2005 Jun; 98(2):142-50. PubMed ID: 15937403
    [Abstract] [Full Text] [Related]

  • 8. Characterization of the inclusion mode of beta-cyclodextrin sulfate and its effect on the chlorpromazine-induced hemolysis of rabbit erythrocytes.
    Shiotani K, Uehata K, Irie T, Hirayama F, Uekama K.
    Chem Pharm Bull (Tokyo); 1994 Nov; 42(11):2332-7. PubMed ID: 7859332
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of neuronal nitric oxide synthase activity by 3-[2-[4-(3-chloro-2-methylphenyl)- 1-piperazinyl]ethyl]-5, 6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate (DY-9760e), a novel neuroprotective agent, in vitro and in cultured neuroblastoma cells in situ.
    Fukunaga K, Ohmitsu M, Miyamoto E, Sato T, Sugimura M, Uchida T, Shirasaki Y.
    Biochem Pharmacol; 2000 Sep 01; 60(5):693-9. PubMed ID: 10927028
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. DY-9760e, a novel calmodulin inhibitor, exhibits cardioprotective effects in the ischemic heart.
    Fukunaga K, Han F, Shioda N, Moriguchi S, Kasahara J, Shirasaki Y.
    Cardiovasc Drug Rev; 2006 Sep 01; 24(2):88-100. PubMed ID: 16961723
    [Abstract] [Full Text] [Related]

  • 12. DY-9760e, a novel calmodulin antagonist with cytoprotective action.
    Sugimura M, Sato T, Nakayama W, Morishima Y, Fukunaga K, Omitsu M, Miyamoto E, Shirasaki Y.
    Eur J Pharmacol; 1997 Oct 01; 336(1):99-106. PubMed ID: 9384259
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. 3-[2-[4-(3-Chloro-2-methylphenylmethyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydro-chloride 3.5 hydrate (DY-9760e) is neuroprotective in rat microsphere embolism: role of the cross-talk between calpain and caspase-3 through calpastatin.
    Han F, Shirasaki Y, Fukunaga K.
    J Pharmacol Exp Ther; 2006 May 01; 317(2):529-36. PubMed ID: 16467455
    [Abstract] [Full Text] [Related]

  • 16. Effect of 2,6-di-O-methyl-alpha-cyclodextrin on hemolysis and morphological change in rabbit's red blood cells.
    Motoyama K, Arima H, Toyodome H, Irie T, Hirayama F, Uekama K.
    Eur J Pharm Sci; 2006 Oct 01; 29(2):111-9. PubMed ID: 16870405
    [Abstract] [Full Text] [Related]

  • 17. Post-ischemic administration of DY-9760e, a novel calmodulin antagonist, reduced infarct volume in the permanent focal ischemia model of spontaneously hypertensive rat.
    Takagi K, Sato T, Shirasaki Y, Narita K, Tamura A, Sano K.
    Neurol Res; 2001 Sep 01; 23(6):662-8. PubMed ID: 11547940
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.